Plasma Concentrations and Renal Clearance of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Cancer Patients Receiving Morphine
- 1 May 1993
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 24 (5) , 413-420
- https://doi.org/10.2165/00003088-199324050-00005
Abstract
The plasma concentrations and renal clearance values of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) were determined in 11 adult cancer patients maintained on a long term oral morphine dosage (10 to 100mg every 4h). Concentrations in plasma and urine were determined by a specific high performance liquid chromatography assay. In this group of patients, whose creatinine clearance values ranged from 52 to 180 ml/min (3.12 to 10.8 L/h), average steady-state plasma concentrations of morphine, M3G and M6G were related (p < 0.01) to the morphine dose per kilogram of bodyweight. The mean total urinary recovery as morphine, M3G and M6G was 74.6 ± 26.5% of the dose. Renal clearance values for M3G and M6G were closely related (r2 = 0.80; p < 0.0005). It was not possible to detect a relationship between the renal clearance of morphine, M3G and M6G, and that of creatinine. The renal tubular handling of all 3 compounds showed wide interindividual variation, and there was evidence of either net renal tubular secretion or reabsorption. There was no apparent relationship between plasma morphine and M6G concentrations and pain relief.Keywords
This publication has 29 references indexed in Scilit:
- The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive‐care patients.British Journal of Clinical Pharmacology, 1992
- Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney.1991
- Clinical Pharmacokinetics of MorphineTherapeutic Drug Monitoring, 1991
- PHARMACOLOGICAL CHARACTERIZATION OF MORPHINE-6-BETA-GLUCURONIDE, A VERY POTENT MORPHINE METABOLITE1989
- Long lasting respiratory depression induced by morphine‐6‐glucuronide?British Journal of Clinical Pharmacology, 1989
- RELATIVE BIOAVAILABILITY OF CONTROLLED RELEASE MORPHINE TABLETS (MST CONTINUS) IN CANCER PATIENTSBritish Journal of Anaesthesia, 1988
- PHARMACOKINETIC DRUG-INTERACTIONS BETWEEN TRIAMTERENE AND RANITIDINE IN HUMANS - ALTERATIONS IN RENAL AND HEPATIC CLEARANCES AND GASTROINTESTINAL ABSORPTION1988
- Morphine-6-glucuronide: Analgesic effects and receptor binding profile in ratsLife Sciences, 1988
- Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.British Journal of Clinical Pharmacology, 1985
- Analgesic Effect of Morphine GlucuronidesThe Tohoku Journal of Experimental Medicine, 1971